Our Core Team

Dr. Carsten Nicolaus is a world- renowned Lyme specialist, dedicating his career to researching, diagnosing, and treating Lyme and other tickborne diseases. He provides mentorship and training to doctors and clinics worldwide and offers personalized support to practitioners with patients who have complex medical histories.

Since 1990, he has advised over 28,000 Lyme patients
from over 80 countries. Dr. Nicolaus has trained over 1,500 doctors since 2006 and has been an active member of ILADS (International Lyme & Associated Diseases Society) since 2007.

Dr. Nicolaus founded the largest Lyme clinic in Europe,
gaining worldwide recognition and praise as a beacon of hope and successful treatment outcomes for patients. He has developed a unique set of protocols and treatment approaches that cutting-edge doctors and clinics have successfully adopted in practice. This targeted approach to treatment is the result of years of frontline clinical care, a dynamic research department, and a training academy, all intrinsically connected and under one roof.

In 2016, Dr. Nicolaus and Dr. Felix Scholz founded Infectolab Americas (USA) to develop the highest quality of tests and diagnostics for viruses, bacteria (including Lyme and other tick-borne diseases), and treatment guidance. They are proud to be an independent owner-run laboratory able to personally support clinics, practitioners and patients and to consult with them regularly.

Dr. Scholz is the CEO of Infectolab Americas. He previously served as Head of the Department of Immunology with an international lab in Wisconsin overseeing their Research and Development Department.

He has spearheaded numerous infectious disease and allergy testing projects and is an expert in assay platforms such as ELISPOT, ELISA, and Flow cytometry.

Dr. Scholz completed a Bachelor of Science in Germany in 2002 and a PhD in Cell Biology at the University of Kiel, Germany in 2006. He completed his Postdoctoral Fellowship at the Mayo Clinic in Rochester, Minnesota (Department of Nephrology) between 2008-2009 where he was an integral part of their research department. He then pursued his Postdoctoral Fellowship at the Center for Immunology at the University of Minnesota.

Dr. Scholz has received numerous awards and grants from the University of Kiel, Germany and the University of Minnesota. He currently has six publications in peer-reviewed journals and six first-author presentations (oral and posters) at national and international conferences.

Dr. Scholz’s passion is research and development. He is dedicated to continuous growth in the field of immunology leading to improvements in the detection
and treatment of modern-day infection.